Dr Reddy's launches a new generic drug in the US
14 July 2015 | News | By BioSpectrum Bureau
Dr Reddy's launches new generic drug in the US
Memantine hydrochloride tablets are a therapeutic equivalent generic version of NAMENDA
Dr Reddy's Laboratories has announced that it has launched Memantine hydrochloride tablets USP, 5 mg and 10 mg, a therapeutic equivalent generic version of NAMENDA (memantine HCl)tablets in the US market.
The NAMENDA (memantine HCl) tablets brand had the US sales of approximately $1.4 billion MAT for the most recent twelve months ending in May 2015, according to IMS Health.
The company's Memantine hydrochloride tablets USP, 5 mg is available in bottle count size of 60 and the Memantine hydrochloride tablets USP, 10 mg are available in bottle count sizes of 60 and 500.
